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Background. The simultaneous assessment of perfusion and function with the use of
technetium 99m sestamibi gated single photon emission computed tomography (SPECT) is
helpful for the detection of myocardial viability, but its value in comparison with more
established methods is not yet defined.
Methods and Results. This study compared low-dose dobutamine (LDD) nitrate-enhanced
gated SPECT with LDD echocardiography for predicting recovery of regional ventricular
function after revascularization in 25 patients with ischemic cardiomyopathy. In both
studies, regional function (wall motion and thickening) at rest, during inotropic stimulation,
and after revascularization was scored by a 4-point scale. In LDD echocardiography, the
prediction of reversible dysfunction was based on the recognition of contractile reserve in
asynergic (hypokinetic or a-dyskinetic) segments. In LDD gated sestamibi SPECT, revers-
ible dysfunction was predicted on the basis of perfusion quantification (sestamibi uptake >
50%) in a-dyskinetic segments and on the basis of contractile reserve in hypokinetic
segments. LDD echocardiography predicted reversible dysfunction with sensitivity, speci-
ficity, and global accuracy of 57%, 85%, and 75%, respectively. The sensitivity and
specificity of LDD gated SPECT for identifying dysfunctional segments capable of func-
tional recovery were 77% and 88%, respectively, with a diagnostic accuracy of 84% (P <
.02 vs LDD echocardiography).
Conclusions. The combined use of 2 different markers of viability, such as cellular integrity
in a-dyskinetic segments and contractile reserve in hypokinetic segments, as permitted by LDD
gated sestamibi SPECT, showed higher predictive accuracy for reversible dysfunction than the
assessment of contractile reserve in all asynergic segments with LDD echocardiography. (J Nucl
Cardiol 2002;9:402-6.)
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The simultaneous assessment of perfusion and
function that is possible with the use of gated single
photon emission computed tomography (SPECT)1 is
helpful for detecting myocardial viability.2 Moreover,
the acquisition of gated SPECT images during low-
dose dobutamine (LDD) infusion permits the detection
of contractile reserve in asynergic segments,3 with
results that are comparable to those of LDD echocar-
diography.4 The combination of perfusion and func-
tional data, including the assessment of contractile
reserve, significantly improved the accuracy of nitrate-
enhanced technetium 99m sestamibi gated SPECT in
detecting viable hibernating myocardium.5 However,
the value of this combined approach in comparison
with a more established method such as LDD echo-
cardiography is still unknown. The aim of this study
was to compare LDD nitrate-enhanced gated sestamibi
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SPECT with LDD echocardiography for predicting
recovery of regional ventricular function after revas-
cularization in patients with chronic coronary artery
disease and left ventricular dysfunction.
METHODS
Patient Population
The study group included 25 patients (23 men; age, 58 
7 years [mean  SD]) with previous myocardial infarction
(anterior in 19) and ischemic cardiomyopathy (left ventricular
ejection fraction  50%), who were referred to our laboratory
for viability assessment. To be included in the study, the
patients had to be scheduled for myocardial revascularization
on the basis of the independent judgment of the referring
physician. The exclusion criteria were recent myocardial in-
farction or unstable angina, presence of heart disease other than
coronary artery disease, atrial fibrillation, and history of sus-
tained ventricular tachycardia. Diabetes was reported in 9
patients, and hypertension in 7. According to coronary angiog-
raphy, 8 patients had 1-vessel, 11 had 2-vessel, and 6 had
3-vessel coronary artery disease. The revascularization proce-
dure was coronary artery bypass graft surgery in 10 patients
and percutaneous transluminal coronary angioplasty in 15.
Study Protocol
Before revascularization, all patients underwent (1) LDD
echocardiography and (2) LDD nitrate-enhanced gated sesta-
mibi SPECT. The studies were performed within 1 week with
a 24-hour interval. -Adrenergic blocking agents were with-
drawn 48 hours before the test. After revascularization (109 
20 days for surgical revascularization and 67  29 days for
coronary angioplasty), resting echocardiography and resting
gated sestamibi SPECT were repeated to evaluate regional
functional changes. All patients gave written informed consent
to participate in the protocol.
Two-dimensional Echocardiography
Two-dimensional echocardiograms were registered with
the patients lying in the left lateral decubitus position through
use of commercially available echocardiographic equipment
(2.5- and 3.5-MHz transducers, Hewlett Packard Sonos 2000)
using all available tomographic planes obtainable from the
parasternal and apical approach. Each study was recorded on
videotape for offline evaluation.
Gated Sestamibi SPECT
The nitrate sestamibi protocol has been described.6,7 After
1 hour of sestamibi (1111 MBq [30 mCi]) injection, baseline
resting gated SPECT was acquired. Immediately thereafter, the
dobutamine study was performed. For the postrevascularization
study, the same dose of sestamibi was injected at rest. Images
were acquired by a dual-head gamma camera (ADAC Vertex)
equipped with high-resolution collimators, with a 15% window
centered on the 140-keV photopeak of Tc-99m. SPECT was
performed in step-and-shoot mode, with 32 projections over a
180° elliptical orbit (matrix size, 64  64; 45 seconds/
projection; 8 frames/cardiac cycle). The studies were recon-
structed by filtered backprojection without attenuation or scat-
ter correction and realigned along the heart axis.
LDD Protocol
Dobutamine infusion was started at a dosage of 5 g/kg
body weight/min for 5 minutes and then increased to 10
g/kg/min for a further 5 minutes.4 The intravenous infusion of
dobutamine was performed with the patient under continuous
electrocardiographic and blood pressure monitoring. Criteria
for early interruption included hypotension, angina, and signif-
icant ventricular arrhythmia. Echocardiographic images were
collected after 3 minutes of the 10-g dosage. Similarly, gated
sestamibi SPECT acquisition was started after 3 minutes of the
10-g dosage, which was maintained until the acquisition was
complete.
Data Analysis
For both echocardiographic and scintigraphic analyses, the
left ventricle was divided into 16 segments that were assigned
to 1 of the 3 coronary territories according to an established
scheme.8 In both studies, regional function (wall motion and
thickening) was assessed visually by consensus of 2 experi-
enced observers using a 4-point scale (1, normal; 2, hypokine-
sis; 3, akinesis; 4, dyskinesis). Interobserver and intraobserver
agreement for regional functional scoring was previously re-
ported.4 Contractile reserve was considered to be present in the
LDD studies when segments with abnormal baseline regional
function exhibited a decrease of 1 grade or more in regional
wall motion score.9 For the perfusion study, tracer uptake was
quantified with the use of an automated program that identified
the segment with peak uptake, set its activity to 100%, and
scaled the other segments in percent of peak activity.7 In LDD
echocardiography, the identification of reversible dysfunction
was based on the presence of contractile reserve in baseline
asynergic segments (score, 2). On LDD nitrate-enhanced
gated sestamibi SPECT, the identification of reversible dys-
function was based on perfusion quantification (sestamibi
uptake  50%) in the instance of baseline a-dyskinetic seg-
ments (score, 3-4) and on contractile reserve in baseline
hypokinetic segments (score, 2).5 An asynergic segment was
considered to have functional recovery in the follow-up control
when, compared with the respective baseline study, it showed
a wall motion improvement of 1 or more grades9 or of 2 or
more grades in the case of dyskinesia.10
Statistical Analysis
Results are expressed as mean  SD. Continuous vari-
ables were compared by the Student t test. The comparison of
proportions was made by the Fisher exact test. Agreement
between baseline gated sestamibi SPECT and echocardiogra-
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phy for regional functional evaluation was assessed by Cohen
kappa statistics. P  .05 was considered significant.
RESULTS
Baseline and Postrevascularization Regional
Ventricular Function
In the 25 patients, a total of 39 vascular territories
including 278 segments were successfully revascular-
ized. Of these, 205 (70 hypokinetic) demonstrated ab-
normal baseline function on echocardiography and 203
(76 hypokinetic) showed abnormal contractility in base-
line gated sestamibi SPECT. In the 271 segments eval-
uated by both techniques (7 segments could not be
evaluated by echocardiography), the exact agreement
between gated sestamibi SPECT and echocardiography
for baseline resting regional function was 56% (153/271;
kappa  0.36). The agreement for precise wall motion
score 1 was 92% (249/271; kappa  0.90). After
revascularization, 75 abnormal segments (34 hypoki-
netic) functionally improved on echocardiography and
75 asynergic segments (30 hypokinetic) showed func-
tional recovery on gated sestamibi SPECT. Before re-
vascularization, mean sestamibi activity was 47% 
20% in the segments without recovery and 57%  16%
in those with reversible dysfunction, and it increased to
52%  18% (P  .0001) and 65%  14% (P 
.000001), respectively, after revascularization.
Prediction of Functional Recovery
Contractile reserve was detected by echocardiogra-
phy in 62 asynergic segments. The presence of contrac-
tile reserve correctly identified 43 asynergic segments
with functional recovery; its absence was registered in
111 of 130 segments with unchanged dysfunction after
revascularization. Thus sensitivity was 57% and speci-
ficity 85%, with an overall accuracy for prediction of
functional recovery of 75%. Table 1 details the results of
LDD echocardiography in hypokinetic versus akinetic
segments.
On gated sestamibi SPECT, contractile reserve cor-
rectly classified 64 hypokinetic segments and perfusion
quantification 106 a-dyskinetic segments (Table 1). The
related sensitivity and specificity values in the whole
cohort of asynergic segments were 77% and 88%,
respectively, without significant differences from the
values obtained by LDD echocardiography. The overall
accuracy for prediction of functional recovery was 84%,
significantly higher than that registered with the use of
LDD echocardiography (P  .02) (Figure 1).
DISCUSSION
Gated SPECT permits the detection of hibernating
myocardium with the use of 2 different markers of
viability, cellular integrity and contractile reserve. Using
LDD nitrate-enhanced gated SPECT, we had previously
demonstrated that the combination of perfusion quanti-
fication and contractile reserve evaluation achieved re-
sults that were significantly superior to perfusion or
contractile reserve data applied separately.5 In this study
the identification of myocardial viability based on per-
Table 1. Results of LDD echocardiography and gated sestamibi SPECT in hypokinetic versus a-dyskinetic
segments
Hypokinetic A-dyskinetic
LDD
echocardiography
Gated SPECT
(contractile reserve)
LDD
echocardiography
Gated SPECT
(sestamibi activity)
Sensitivity 23/34 (68%) 22/30 (73%) 20/41 (49%)* 36/45 (80%)*
Specificity 30/36 (83%) 42/46 (91%) 81/94 (86%) 70/82 (85%)
Accuracy 53/70 (76%) 64/76 (84%) 101/135 (75%) 106/127 (83%)
*P  .005.
Figure 1. Histogram comparing the results of LDD gated
sestamibi SPECT (black bars) versus LDD echocardiography
(white bars) for the prediction of reversible dysfunction.
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fusion quantification in a-dyskinetic segments and on
contractile reserve detection in hypokinetic segments by
means of LDD nitrate-enhanced gated sestamibi SPECT
showed higher predictive values for reversible dysfunc-
tion than evaluation of contractile reserve in all asynergic
segments by means of LDD echocardiography. The
significantly higher predictive accuracy of the nuclear
technique mainly results from the superior sensitivity in
a-dyskinetic segments (80% vs 49%; P  .005), and this
finding confirms that perfusion quantification is advan-
tageous over contractile reserve evaluation in this most
important subset of dysfunctional segments. In previous
comparisons between perfusion scintigraphy and LDD
echocardiography, the sensitivity of perfusion imaging
for the detection of viable hibernating myocardium
appeared to be higher than that of echocardiography in
a-dyskinetic segments, although its specificity was found
to be significantly lower in hypokinetic segments.11,12
Histopathologic observations in explanted hearts suggest
that cellular integrity and contractile reserve provide
complementary data for the assessment of tissue viabil-
ity.13 These findings have been confirmed in clinical
settings. The combined evaluation of rest-redistribution
thallium 201 and LDD echocardiography significantly
enhanced the identification of viable myocardium in
patients with chronic coronary artery disease.14 The main
advantage of LDD nitrate-enhanced gated SPECT is that
for each subset of dysfunctional segments, the most
appropriate viability marker can be used within a single
test.
Some limitations of this study must be considered. A
longer follow-up could have increased the detection of
functional recovery and hence decreased the incidence of
apparently false-positive responses for both imaging
methods. We used a low-dose infusion protocol. The
additional high-dose infusion has been reported to im-
prove the accuracy in identifying viable myocardium,
and the biphasic response is considered the most reliable
marker of preserved viability when dobutamine echocar-
diography is used.15 The ability to monitor functional
changes could be an advantage of echocardiography over
gated SPECT. However, recent data using short-time
collection methods for gated imaging have demonstrated
the possibility of assessing the biphasic response as
well.16 Silent restenosis or graft occlusion could not be
completely ruled out, because angiography was not
performed at follow-up. However, none of the patients
had a worsened perfusion pattern after revascularization.
Finally, the results of echocardiography could have been
improved by the use of cine-loop or quad-screen images.
In conclusion, LDD nitrate-enhanced gated SPECT
is a feasible imaging technique, which, in a single study,
provides quantification of regional perfusion and evalu-
ation of segmental contractile reserve, thereby obviating
the need for separate tests to predict reversible dysfunc-
tion accurately in patients with ischemic cardiomyopa-
thy.
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